TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Karo Pharma AS
Closing information (x1000 NOK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover | 640,717 | 504,255 | 406,907 |
Financial expenses | 9,255 | 4,893 | 5,113 |
Earnings before taxes | 126,201 | 139,942 | 107,704 |
Total assets | 381,062 | 378,532 | 282,382 |
Current assets | 338,348 | 331,928 | 225,603 |
Current liabilities | 232,775 | 222,926 | 148,571 |
Equity capital | 148,287 | 152,743 | 131,169 |
- share capital | 6,798 | 6,798 | 6,798 |
Employees (average) | 22 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency | 38.9% | 40.4% | 46.5% |
Turnover per employee | 18,496 | ||
Profit as a percentage of turnover | 19.7% | 27.8% | 26.5% |
Return on assets (ROA) | 35.5% | 38.3% | 40.0% |
Current ratio | 145.4% | 148.9% | 151.8% |
Return on equity (ROE) | 85.1% | 91.6% | 82.1% |
Change turnover | 136,462 | 97,348 | -36,143 |
Change turnover % | 27% | 24% | -8% |
Chg. No. of employees | 0 | ||
Chg. No. of employees % | 0% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.